Jump to content
RemedySpot.com

RESEARCH - Peripheral neuropathy in two patients with RA receiving Remicade

Rate this topic


Guest guest

Recommended Posts

Clin Rheumatol. 2007 Feb;26(2):258-60. Epub 2006 Jul 6.

Peripheral neuropathy in two patients with rheumatoid arthritis receiving

infliximab treatment.

Department of Internal Medicine, Euroclinic Hospital, 9 Athanasiadou str,

115 21, Athens, Greece, mtektonidou@....

Antitumor necrosis alpha agents have been successfully used for the

treatment of rheumatoid and seronegative arthritis, Crohn's disease,

psoriasis, and severe cases of vasculitis. Several side effects have been

observed in patients receiving these agents including hypersensitivity

reactions, infections, drug-induced lupus, or demyelinating syndromes. The

presence of peripheral neuropathy has been reported only in isolated cases.

We describe two cases of peripheral neuropathy which occurred in patients

with rheumatoid arthritis receiving infliximab treatment, one with

multifocal motor neuropathy with conduction block and another with axonal

sensory polyneuropathy, reversed upon discontinuation of infliximab and

intravenous gammaglobulin treatment.

PMID: 16683176

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed & cmd=Retrieve & dopt=Abstra\

ctPlus & list_uids=16683176

Not an MD

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...